Crescent Biopharma Inc.

NASDAQ: CBIO · Real-Time Price · USD
13.89
-0.04 (-0.29%)
At close: Aug 15, 2025, 3:59 PM
14.06
1.19%
After-hours: Aug 15, 2025, 07:27 PM EDT

Crescent Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025
Period Ending Jun 30, 2025
Revenue
n/a
Cost of Revenue
n/a
Gross Profit
n/a
Operating Income
-21.03M
Interest Income
313K
Pretax Income
-21.79M
Net Income
-21.79M
Selling & General & Admin
8.95M
Research & Development
12.08M
Other Expenses
n/a
Operating Expenses
21.03M
Interest Expense
1.07M
Selling & Marketing Expenses
n/a
Cost & Expenses
21.03M
Income Tax Expense
n/a
Shares Outstanding (Basic)
864.21K
Shares Outstanding (Diluted)
1.02M
EPS (Basic)
-25.21
EPS (Diluted)
-21.37
EBITDA
-20.72M
EBIT
-20.72M
Depreciation & Amortization
n/a